Search

Search any products, services and so on here.

About 16396 result(s)

Global Exparel Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4077
  • Pages: 78
  • Figures: 103
  • Views: 35
  • From $4,900

Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy.  The global Exparel market is projected to grow from US$ 685 million in 2024 to US$ 930.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. Liposomal Bupivacaine gained significant attention and...


Global Bupivacaine Liposome Injectable Suspension Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4078
  • Pages: 74
  • Figures: 101
  • Views: 37
  • From $4,900

Liposomal bupivacaine has been approved by the US Food and Drug Administration for local infiltration for pain relief after bunionectomy and hemorrhoidectomy.  The global Bupivacaine Liposome Injectable Suspension market is projected to grow from US$ 532 million in 2024 to US$ 754.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period. The increasing focus...


Global Liposomal Paclitaxel Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4079
  • Pages: 74
  • Figures: 100
  • Views: 34
  • From $4,900

A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. The global Liposomal Paclitaxel market is projected to grow from US$ 866 million in 2024 to US$ 1299.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period. The Liposomal Paclitaxel market has experienc...


Global Paclitaxel Drug Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4080
  • Pages: 90
  • Figures: 114
  • Views: 40
  • From $4,900

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". The global Paclitaxel Drug market is projected to grow from US$ 120.8 million in 2024 to US$ 139.3 million...


Global Liposomal Irinotecan Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4081
  • Pages: 79
  • Figures: 103
  • Views: 32
  • From $4,900

Irinotecan, sold under the brand name Camptosar among others, is a medication used to treat colon cancer, and small cell lung cancer.  The global Liposomal Irinotecan market is projected to grow from US$ 799 million in 2024 to US$ 1148.2 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period. The Liposomal Irinotecan market has been influenced by the need for...


Global Neurotrophic Keratitis Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4110
  • Pages: 114
  • Figures: 134
  • Views: 44
  • From $4,900

Neurotrophic keratitis (NK) is a degenerative disease of the cornea caused by damage of the trigeminal nerve, which results in impairment of corneal sensitivity, spontaneous corneal epithelium breakdown, poor corneal healing and development of corneal ulceration, melting and perforation. Market Analysis and Insights: Global Neurotrophic Keratitis Market The global Neurotrophic Keratitis market i...


Global Neurotrophic Keratitis Therapeutics Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4111
  • Pages: 112
  • Figures: 135
  • Views: 47
  • From $4,900

Neurotrophic keratitis (NK) is a degenerative disease of the cornea caused by damage of the trigeminal nerve, which results in impairment of corneal sensitivity, spontaneous corneal epithelium breakdown, poor corneal healing and development of corneal ulceration, melting and perforation. Market Analysis and Insights: Global Neurotrophic Keratitis Therapeutics Market The global Neurotrophic Kerat...


Global Non-Invasive Prenatal Testing Kit Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4113
  • Pages: 93
  • Figures: 115
  • Views: 47
  • From $4,900

Noninvasive prenatal testing (NIPT) is a method to assess the risk that the fetus will be born with certain genetic abnormalities.  Market Analysis and Insights: Global Non-Invasive Prenatal Testing Kit Market The global Non-Invasive Prenatal Testing Kit market is projected to grow from US$ 3585 million in 2024 to US$ 5688.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.0% during...


Global Acute Agitation and Aggression Therapeutics Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4114
  • Pages: 96
  • Figures: 110
  • Views: 59
  • From $4,900

With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas. Market Analysis and Insights: Global Acute Agitation and Aggression Therapeutics Market The global Acute Agitation and Aggression Therapeutics market is projected to grow from US$ 2263 milli...


Global Acute Agitation and Aggression Drugs Market Insights, Forecast to 2030

  • Mar 11, 25
  • ID: 4115
  • Pages: 86
  • Figures: 114
  • Views: 60
  • From $4,900

With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas. Market Analysis and Insights: Global Acute Agitation and Aggression Drugs Market The global Acute Agitation and Aggression Drugs market is projected to grow from US$ 935 million in 2024 to U...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232